Get the latest Science News and Discoveries
Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with metastatic prostate cancer - EurekAlert
Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of therapy response and resistance in patients with metastatic disease.
None
Or read this on Eureka Alert